Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("prostate cancer")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 14825

  • Page / 593
Export

Selection :

  • and

Complexed PSA in routine diagnosisOREMEK, G. M; SAPOUTZIS, N; EDEN, F et al.Anticancer research. 2003, Vol 23, Num 2A, pp 975-977, issn 0250-7005, 3 p.Conference Paper

11C-acetate PET imaging of prostate cancer: Detection of recurrent disease at PSA relapse. CommentaryOYAMA, Nobuyuki; MILLER, Tom R; DIMITRAKOPOULOU-STRAUSS, Antonia et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 4, pp 549-558, issn 0161-5505, 10 p.Article

Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cellsNISHIMURA, Kenji; MATSUMIYA, Kiyomi; MIURA, Hidenobu et al.International journal of andrology (Print). 2003, Vol 26, Num 3, pp 175-179, issn 0105-6263, 5 p.Article

One pot radiofluorination of a new potential PSMA ligand [Al18F]NOTA-DUPA-PepMALIK, Noeen; ZLATOPOLSKIY, Boris; MACHULLA, Hans-Juergen et al.Journal of labelled compounds & radiopharmaceuticals. 2012, Vol 55, Num 9-10, pp 320-325, issn 0362-4803, 6 p.Article

Association of the genetic polymorphism in cytochrome p450 (CYP) 11 with risk of familial prostate cancer in a Japanese population: a case-control studySUZUKI, Kazuhiro; MATSUI, Hiroshi; ITO, Kazuto et al.Cancer letters. 2003, Vol 195, Num 2, pp 177-183, issn 0304-3835, 7 p.Article

Intraindividual comparison of [11C]acetate and [11C]choline pet for detection of metastases of prostate cancerKOTZERKE, J; VOLKMER, B. G; GLOTTING, G et al.Nuclear-Medizin. 2003, Vol 42, Num 1, pp 25-30, issn 0029-5566, 6 p.Article

VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawalGUTIERREZ-CANAS, Irene; RODRIGUEZ-HENCHE, Nieves; BOLANOS, Oscar et al.British journal of pharmacology. 2003, Vol 139, Num 5, pp 1050-1058, issn 0007-1188, 9 p.Article

Adjuvant radiotherapy in locally confined prostate cancerSCHÄFER, Ulrich; WITT, Frank; MICKE, Oliver et al.Anticancer research. 2003, Vol 23, Num 2A, pp 983-985, issn 0250-7005, 3 p.Conference Paper

Androgen receptor and prostate cancer invasionBONACCORSI, Lorella; MURATORI, Monica; CARLONI, Vinicio et al.International journal of andrology (Print). 2003, Vol 26, Num 1, pp 21-25, issn 0105-6263, 5 p.Article

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cellsHOFFMAN, Timothy J; GALI, Hariprasad; SMITH, C. Jeffrey et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 5, pp 823-831, issn 0161-5505, 9 p.Article

Neuroendocrine differentiation in prostate cancer: Implications for newtreatment modalitiesVASHCHENKO, Nadezda; ABRAHAMSSON, Per-Anders.European urology. 2005, Vol 47, Num 2, pp 147-155, issn 0302-2838, 9 p.Article

Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablationLAMB, Dolores J; PUXEDDU, Efisio; MALIK, Nusrat et al.Journal of andrology. 2003, Vol 24, Num 2, pp 215-225, issn 0196-3635, 11 p.Article

Regulation of prostate-specific antigen gene expression by an LH-RH analogue in human prostatic cellsSICA, Gigliola; ZELANO, Giovanni; SETTESOLDI, Daniela et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1283-1287, issn 0250-7005, 5 p.Article

Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapyCHEUNG, Rex; TUCKER, Susan L; LEI DONG et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 5, pp 1234-1240, issn 0360-3016, 7 p.Article

Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migrationLIU, Jun-Wei; SHEN, Jian-Jun; TANZILLO-SWARTS, Angela et al.Oncogene (Basingstoke). 2003, Vol 22, Num 10, pp 1475-1485, issn 0950-9232, 11 p.Article

A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancerTAKAMIYA, Robert; WEINBERG, Vivian; YOUNG, C. Dale et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1073-1078, issn 0360-3016, 6 p.Conference Paper

Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: Feasibility and toxicityOH, William K; KAPLAN, Irving D; FEBBO, Philip et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 312-316, issn 0277-3732, 5 p.Article

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIMICHALSKI, Jeff M; WINTER, Kathryn; SANDLER, Howard M et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 192-198, issn 0360-3016, 7 p.Article

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implicationsSTOCK, Richard G; STONE, Nelson N; CESARETTI, Jamie A et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 2, pp 448-453, issn 0360-3016, 6 p.Article

Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?NGUYEN, Khanh H; HORWITZ, Eric M; HANLON, Alexandra L et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 377-383, issn 0360-3016, 7 p.Conference Paper

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinomaROSSER, Charles J; REYES, Adriana O; VAKAR-LOPEZ, Funda et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 1-6, issn 0360-3016, 6 p.Article

Definitive radiotherapy of prostate cancer: The possible role of staging lymphadenectomyFOSSA, Sophie D; LILLEBY, Wolfgang; WAEHRE, Hakon et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 33-41, issn 0360-3016, 9 p.Article

Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapySYMON, Zvi; GRIFFITH, Kent A; MCLAUGHLIN, P. William et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 384-390, issn 0360-3016, 7 p.Article

Shared decision-making: Results from an interdisciplinary consulting service for prostate cancerSCHOSTAK, M; WIEGEL, T; MÜLLER, M et al.World journal of urology (Print). 2004, Vol 22, Num 6, pp 441-448, issn 0724-4983, 8 p.Article

Altered localization and activity of the intracellular tyrosine kinase BKR/Sik in prostate tumor cellsDERRY, Jason J; PRINS, Gail S; RAY, Vera et al.Oncogene (Basingstoke). 2003, Vol 22, Num 27, pp 4212-4220, issn 0950-9232, 9 p.Article

  • Page / 593